American Academy of Dermatology
930 E. Woodfield Road
166 articles about American Academy of Dermatology
New Study Reveals That Some Children With Common Form of Eczema Should Also Be Tested for Allergic Reactions
Eczema, which is a group of medical conditions that causes inflamed, irritated, and often itchy skin, affects millions of people worldwide.
American Academy of Dermatology launches innovative project to improve outcomes for patients with life-threatening pustular psoriasis
The American Academy of Dermatology is launching an innovative breakthrough project to develop educational resources to improve the evaluation, diagnosis, and treatment of patients suffering from generalized pustular psoriasis, a rare form of psoriasis that causes widespread, pus-filled blisters, called pustules.
New American Academy of Dermatology Survey Shows Most Americans Are Not Concerned About Skin Cancer, Even if They Are at Risk
As an African American female, Ilia Smith didn't think she would get melanoma. However, after years of tanning and being outdoors, her life changed drastically when she was diagnosed with stage 2 melanoma.
AAD 2023: Late-Breaking Phase III Results Demonstrate nemolizumab’s Significant Impact on Prurigo Nodularis
Galderma, the leading company solely dedicated to advancing the future of dermatology, premiered the positive phase III results from the OLYMPIA 2 trial evaluating the efficacy, safety, pharmacokinetics and immunogenicity of nemolizumab compared with placebo in adult patients with prurigo nodularis.
Biofrontera Inc. announced that it will be hosting a booth showcasing its innovative, FDA-approved products at the 2023 American Academy of Dermatology Annual Meeting taking place March 17-21, 2023 in New Orleans, LA.
Three new officers and four new board members will be installed immediately upon conclusion of the 2023 Annual Meeting of the American Academy of Dermatology, the world's largest dermatologic society.
The 2023 American Academy of Dermatology Annual Meeting will take place March 17-21 at the Ernest N. Morial Convention Center in New Orleans.
American Academy of Dermatology Issues Updated Guidelines for the Management of Atopic Dermatitis in Adults With Topical Therapies
Often called eczema or atopic eczema, atopic dermatitis is a common skin condition, affecting 1 in 10 Americans.
New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting
UCB, a global biopharmaceutical company, announced that it is presenting 11 abstracts on bimekizumab in the treatment of adults with moderate to severe plaque psoriasis at the 2022 American Academy of Dermatology Annual Meeting in Boston, Massachusetts, U.S., on March 25-29, including a late breaking oral platform presentation and 10 posters.
Late-breaking Phase 3 Data at AAD 2022 Show Dupixent® (dupilumab) Significantly Improved Signs and Symptoms of Prurigo Nodularis
Regeneron Pharmaceuticals, Inc. and Sanofi announced that detailed positive results from the Phase 3 PRIME2 trial evaluating the efficacy and safety of Dupixent® were presented in a late-breaking session at the American Academy of Dermatology 2022 Annual Meeting.
Press release: Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis
Detailed positive results from the Phase 3 PRIME2 trial evaluating the safety and efficacy of Dupixent® was presented in a late-breaking session at the American Academy of Dermatology 2022 Annual Meeting.
Evelo Biosciences Presents Late-Breaking Oral Abstract on Data from Phase 2 Trial of EDP1815 in Psoriasis at 2022 American Academy of Dermatology Annual Meeting
Evelo Biosciences, Inc. presented a late-breaking oral abstract on data from a Phase 2 trial of EDP1815 in psoriasis at the 2022 American Academy of Dermatology Annual Meeting, being held March 25-29 in Boston, Massachusetts.
Advanced Dermatology and Cosmetic Surgery Chief Medical Officer Dr. Mark Kaufmann Assumes Presidency of the American Academy of Dermatology
Advanced Dermatology and Cosmetic Surgery announces that, board-certified dermatologist Mark Kaufmann, MD, FAAD, begins his one-year term as president of the American Academy of Dermatology at the conclusion of the 2022 AAD Annual Meeting in Boston.
The start of summer means more tank tops and shorts, and for some people, a pesky new skin condition they may not have noticed before.
Confused About Sunscreen? New American Academy of Dermatology Survey Shows Americans Need a Refresher on Sunscreen Application and SPF
Board-certified dermatologist goes beyond the numbers to ensure consumers are sun-safe heading into Memorial Day weekend
New American Academy of Dermatology Survey Finds One-Third of Americans Fail Basic Quiz on Skin Cancer and Sun Exposure
In recognition of Skin Cancer Awareness Month in May, dermatologists share how the public can #PracticeSafeSun to reduce their risk of skin cancer
The AAD VMX 2021, a virtual meeting experience taking place April 23-25, will feature the latest information on skin, hair and nails, presented by world-renowned experts in the field of dermatology.
How to Prepare for a Telemedicine Appointment; American Academy of DermatologyTips from board-certified dermatologists
Consumer demand for virtual health care has exploded during the COVID-19 pandemic. Thanks to telemedicine, patients with new concerns and those with chronic conditions can have an appointment with a board-certified physician from the comfort and safety of their homes.
How to Prevent and Treat Dry, Chapped Lips; American Academy of DermatologyTips from board-certified dermatologists
For many people, winter skin probably conjures up images of dry, cracked hands, flaky skin, and windburn.
Tips To Avoid Spreading Molluscum Contagiosum; American Academy of Dermatology The common and highly contagious skin condition mostly affects children ages 1 to 10
Molluscum contagiosum is a common and highly contagious skin condition caused by a virus. According to dermatologists from the American Academy of Dermatology, the condition mostly affects children — adults are often immune to the infection — and causes pearly, flesh-colored bumps to appear on the skin.